MAPT and Alzheimer disease: We found that passive immunization with monoclonal antibody 43D against tau 6–18 could reduce not only tau but also Aβ pathology in 3×Tg-AD mice and that the N-terminal proximal domain of tau was a more effective target for passive immunization than the N-terminal distal domains of tau.